bioAffinity Technologies (BIAF) Convertible Debt (2021 - 2022)
bioAffinity Technologies (BIAF) posted quarterly Convertible Debt of $325000.0 for Q4 2022, down 87.5% year-over-year from $2.6 million in Q4 2021, and down 87.5% quarter-over-quarter from $2.6 million in Q3 2022.
bioAffinity Technologies (BIAF) Convertible Debt (2021 - 2022) Analysis & Trends
bioAffinity Technologies (BIAF) has reported Convertible Debt for 2 consecutive years, with $325000.0 the latest figure, recorded in Q4 2022.
- In Q4 2022, Convertible Debt fell 87.5% year-over-year to $325000.0; the TTM figure through Dec 2022 stood at $325000.0 (down 87.5% YoY), while the FY2022 annual figure was $325000.0, down 87.5% from the prior year.
- Convertible Debt slipped to $325000.0 in Q4 2022 per BIAF's latest filing, from $2.6 million in the prior quarter.
- Across five years, Convertible Debt topped out at $2.6 million in Q4 2021 and bottomed at $325000.0 in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn |
| 10 | bioAffinity Technologies | 2.38 Mn | -721,990.64 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 325,000.00 |
| Sep 30, 2022 | 2.60 Mn |
| Mar 31, 2022 | 2.60 Mn |
| Dec 31, 2021 | 2.60 Mn |
| Sep 30, 2021 | 900,000.00 |